The DOI matches its Crossref record; 346 of the 346 references it cites were found in a registry or an index.
Molecular biomarkers in acute myeloid leukemia
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–346 of 346
Dnmt3a loss predisposes murine hematopoietic stem cells to malignant transformation
Mayle, A., Yang, L., Rodriguez, B., Zhou, T., Chang, E., Curry, C. V., Challen, G. A., Li, W., Wheeler, D., Rebel, V. I., et al. (2015) · Blood · doi:10.1182/blood-2014-08-594648 · Cited by 235
Risk Assessment in Patients with Acute Myeloid Leukemia and a Normal Karyotype
Bienz, M., Ludwig, M., Mueller, B. U., Oppliger Leibundgut, E., Ratschiller, D., Solenthaler, M., Fey, M. F., & Pabst, T. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-1552 · Cited by 235
van Waalwijk van Doorn-Khosrovani, S. B., Erpelinck, C., Meijer, J., van Oosterhoud, S., van Putten, W. L. J., Valk, P. J. M., Berna Beverloo, H., Tenen, D. G., Löwenberg, B., & Delwel, R. (2003) · The Hematology Journal · doi:10.1038/sj.thj.6200216 · Cited by 235
Axitinib effectively inhibits BCR-ABL1(T315I) with a distinct binding conformation
Pemovska, T., Johnson, E., Kontro, M., Repasky, G. A., Chen, J., Wells, P., Cronin, C. N., McTigue, M., Kallioniemi, O., Porkka, K., et al. (2015) · Nature · doi:10.1038/nature14119 · Cited by 234
Lord, J. D., McIntosh, B. C., Greenberg, P. D., & Nelson, B. H. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.5.2533 · Cited by 227
Prevalence, clinical profile, and prognosis of NPM mutations in AML with normal karyotype
Boissel, N. (2005) · Blood · doi:10.1182/blood-2005-05-2174 · Cited by 224
Structural and Functional Alterations of FLT3 in Acute Myeloid Leukemia
Meshinchi, S., & Appelbaum, F. R. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1123 · Cited by 224
Cell culture, oxidative stress, and antioxidants: Avoiding pitfalls
Halliwell, B. (2014) · Biomedical Journal · doi:10.4103/2319-4170.128725 · Cited by 222
TET1 plays an essential oncogenic role in MLL -rearranged leukemia
Huang, H., Jiang, X., Li, Z., Li, Y., Song, C.-X., He, C., Sun, M., Chen, P., Gurbuxani, S., Wang, J., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310656110 · Cited by 220
Role of Jak Kinases and STATs in Cytokine Signal Transduction
Leonard, W. J. (2001) · International Journal of Hematology · doi:10.1007/bf02981951 · Cited by 215
JAK-STAT signaling in cancer: From cytokines to non-coding genome
Pencik, J., Pham, H. T. T., Schmoellerl, J., Javaheri, T., Schlederer, M., Culig, Z., Merkel, O., Moriggl, R., Grebien, F., & Kenner, L. (2016) · Cytokine · doi:10.1016/j.cyto.2016.06.017 · Cited by 215
Brandts, C. H., Sargin, B., Rode, M., Biermann, C., Lindtner, B., Schwäble, J., Buerger, H., Müller-Tidow, C., Choudhary, C., McMahon, M., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0422 · Cited by 212
Krupka, C., Kufer, P., Kischel, R., Zugmaier, G., Bögeholz, J., Köhnke, T., Lichtenegger, F. S., Schneider, S., Metzeler, K. H., Fiegl, M., et al. (2014) · Blood · doi:10.1182/blood-2013-08-523548 · Cited by 208
Chou, W.-C., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Ko, B.-S., Wu, S.-J., Huang, S.-Y., Hsu, S.-C., et al. (2010) · Blood · doi:10.1182/blood-2009-11-253070 · Cited by 204
Delaunay, J. (2003) · Blood · doi:10.1182/blood-2002-11-3527 · Cited by 198
Incidence, survival and prevalence of myeloid malignancies in Europe
Visser, O., Trama, A., Maynadié, M., Stiller, C., Marcos-Gragera, R., De Angelis, R., Mallone, S., Tereanu, C., Allemani, C., Ricardi, U., et al. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.05.024 · Cited by 195
Potential mechanisms of resistance to venetoclax and strategies to circumvent it
Tahir, S. K., Smith, M. L., Hessler, P., Rapp, L. R., Idler, K. B., Park, C. H., Leverson, J. D., & Lam, L. T. (2017) · BMC Cancer · doi:10.1186/s12885-017-3383-5 · Cited by 195
Fresquet, V., Rieger, M., Carolis, C., García-Barchino, M. J., & Martinez-Climent, J. A. (2014) · Blood · doi:10.1182/blood-2014-03-560284 · Cited by 188
DNMT3A mutations and response to the hypomethylating agent decitabine in acute myeloid leukemia
Metzeler, K. H., Walker, A., Geyer, S., Garzon, R., Klisovic, R. B., Bloomfield, C. D., Blum, W., & Marcucci, G. (2012) · Leukemia · doi:10.1038/leu.2011.342 · Cited by 186
Paschka, P., Du, J., Schlenk, R. F., Gaidzik, V. I., Bullinger, L., Corbacioglu, A., Späth, D., Kayser, S., Schlegelberger, B., Krauter, J., et al. (2013) · Blood · doi:10.1182/blood-2012-05-431486 · Cited by 185
Tomita, A., Kiyoi, H., & Naoe, T. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1354-4 · Cited by 179
Chou, W.-C., Lei, W.-C., Ko, B.-S., Hou, H.-A., Chen, C.-Y., Tang, J.-L., Yao, M., Tsay, W., Wu, S.-J., Huang, S.-Y., et al. (2011) · Leukemia · doi:10.1038/leu.2010.267 · Cited by 177
Snijder, B., Vladimer, G. I., Krall, N., Miura, K., Schmolke, A.-S., Kornauth, C., Lopez de la Fuente, O., Choi, H.-S., van der Kouwe, E., Gültekin, S., et al. (2017) · The Lancet Haematology · doi:10.1016/s2352-3026(17)30208-9 · Cited by 177
Acute Myeloid Leukemia, Version 2.2013
O’Donnell, M. R., Tallman, M. S., Abboud, C. N., Altman, J. K., Appelbaum, F. R., Arber, D. A., Attar, E., Borate, U., Coutre, S. E., Damon, L. E., et al. (2013) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2013.0127 · Cited by 175
Dawson, M. A., Gudgin, E. J., Horton, S. J., Giotopoulos, G., Meduri, E., Robson, S., Cannizzaro, E., Osaki, H., Wiese, M., Putwain, S., et al. (2014) · Leukemia · doi:10.1038/leu.2013.338 · Cited by 175
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove, C. S., & Vassiliou, G. S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015974 · Cited by 172
Li, Y., Gao, L., Luo, X., Wang, L., Gao, X., Wang, W., Sun, J., Dou, L., Li, J., Xu, C., et al. (2013) · Blood · doi:10.1182/blood-2012-07-444729 · Cited by 167
Perspective: A Program to Improve Protein Biomarker Discovery for Cancer
Aebersold, R., Anderson, L., Caprioli, R., Druker, B., Hartwell, L., & Smith, R. (2005) · Journal of Proteome Research · doi:10.1021/pr050027n · Cited by 161
Konoplev, S. N., Rassidakis, G. Z., Estey, E. H., Kantarjian, H. M., Liakou, C. I., Huang, X., Xiao, L., Andreeff, M., Konopleva, M. Y., & Medeiros, L. J. (2007) · Cancer · doi:10.1002/cncr.22510 · Cited by 160
Aberrant CpG island methylation in acute myeloid leukemia is accentuated at relapse
Kroeger, H., Jelinek, J., Estécio, M. R. H., He, R., Kondo, K., Chung, W., Zhang, L., Shen, L., Kantarjian, H. M., Bueso-Ramos, C. E., et al. (2008) · Blood · doi:10.1182/blood-2007-11-126227 · Cited by 159
S100A9 Is a Novel Ligand of EMMPRIN That Promotes Melanoma Metastasis
Hibino, T., Sakaguchi, M., Miyamoto, S., Yamamoto, M., Motoyama, A., Hosoi, J., Shimokata, T., Ito, T., Tsuboi, R., & Huh, N.-H. (2013) · Cancer Research · doi:10.1158/0008-5472.can-11-3843 · Cited by 158
Neubauer, A., Maharry, K., Mrózek, K., Thiede, C., Marcucci, G., Paschka, P., Mayer, R. J., Larson, R. A., Liu, E. T., & Bloomfield, C. D. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.0418 · Cited by 158
Kantarjian, H. M., Roboz, G. J., Kropf, P. L., Yee, K. W. L., O'Connell, C. L., Tibes, R., Walsh, K. J., Podoltsev, N. A., Griffiths, E. A., Jabbour, E., et al. (2017) · The Lancet Oncology · doi:10.1016/s1470-2045(17)30576-4 · Cited by 158
Quantitative DNA methylation predicts survival in adult acute myeloid leukemia
Bullinger, L., Ehrich, M., Döhner, K., Schlenk, R. F., Döhner, H., Nelson, M. R., & van den Boom, D. (2009) · Blood · doi:10.1182/blood-2009-03-211003 · Cited by 157
Recent developments in immunotherapy of acute myeloid leukemia
Lichtenegger, F. S., Krupka, C., Haubner, S., Köhnke, T., & Subklewe, M. S. (2017) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0505-0 · Cited by 157
Epigenetics Meets Genetics in Acute Myeloid Leukemia: Clinical Impact of a Novel Seven-Gene Score
Marcucci, G., Yan, P. S., Maharry, K. S., Frankhouser, D. E., Nicolet, D., Metzeler, K. H., Kohlschmidt, J., Mrózek, K., Wu, Y.-Z., Bucci, D. M., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2013.50.6337 · Cited by 156
Clinical significance of microRNAs in chronic and acute human leukemia
Yeh, C.-H., Moles, R., & Nicot, C. (2016) · Molecular Cancer · doi:10.1186/s12943-016-0518-2 · Cited by 152
Translational implications of somatic genomics in acute myeloid leukaemia
Meyer, S. C., & Levine, R. L. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70008-7 · Cited by 149
Chromosomal translocations: revisited yet again
Rowley, J. D. (2008) · Blood · doi:10.1182/blood-2008-04-097931 · Cited by 149
Ok, C. Y., Patel, K. P., Garcia‐Manero, G., Routbort, M. J., Peng, J., Tang, G., Goswami, M., Young, K. H., Singh, R. R., Medeiros, L. J., et al. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0139-z · Cited by 146
Role of DNMT3A, TET2, and IDH1/2 mutations in pre-leukemic stem cells in acute myeloid leukemia
Chan, S. M., & Majeti, R. (2013) · International Journal of Hematology · doi:10.1007/s12185-013-1407-8 · Cited by 142
Ohgami, R. S., Ma, L., Merker, J. D., Gotlib, J. R., Schrijver, I., Zehnder, J. L., & Arber, D. A. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.160 · Cited by 142
Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics
Gregory, T. K., Wald, D. N., Chen, Y., Vermaat, J. M., Xiong, Y., & Tse, W. W. (2009) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-2-23 · Cited by 142
Qian, H., Tryggvason, K., Jacobsen, S. E. W., & Ekblom, M. (2006) · Blood · doi:10.1182/blood-2005-10-3932 · Cited by 141
Renneville, A., Boissel, N., Nibourel, O., Berthon, C., Hélevaut, N., Gardin, C., Cayuela, J., Hayette, S., Reman, O., Contentin, N., et al. (2012) · Leukemia · doi:10.1038/leu.2011.382 · Cited by 139
Targeting the FMS-like tyrosine kinase 3 in acute myeloid leukemia
Swords, R. T., Freeman, C. L. L., & Giles, F. J. (2012) · Leukemia · doi:10.1038/leu.2012.114 · Cited by 139
Thomas, X., Campos, L., Mounier, C., Cornillon, J., Flandrin‐Gresta, P., Le, Q., Piselli, S., & Guyotat, D. (2005) · Leukemia Research · doi:10.1016/j.leukres.2005.02.010 · Cited by 138
Prognostic value of FLT3 mutations among different cytogenetic subgroups in acute myeloid leukemia
Santos, F. P. S., Jones, D. M., Qiao, W., Cortes, J. E., Ravandi, F., Estey, E. E., Verma, D., Kantarjian, H. M., & Borthakur, G. M. (2010) · Cancer · doi:10.1002/cncr.25670 · Cited by 133
Aigner, M., Feulner, J., Schaffer, S., Kischel, R., Kufer, P., Schneider, K., Henn, A., Rattel, B., Friedrich, M., Baeuerle, P. A., et al. (2012) · Leukemia · doi:10.1038/leu.2012.341 · Cited by 130
Leverson, J. D., Sampath, D., Souers, A. J., Rosenberg, S. H., Fairbrother, W. J., Amiot, M., Konopleva, M. Y., & Letai, A. G. (2017) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-0797 · Cited by 128
Aberrant activation of the PI3K/mTOR pathway promotes resistance to sorafenib in AML
Lindblad, O., Cordero, E., Puissant, A., Macaulay, L., Ramos, A. H., Kabir, N. N., Sun, J., Vallon‐Christersson, J., Haraldsson, K., Hemann, M. T., et al. (2016) · Oncogene · doi:10.1038/onc.2016.41 · Cited by 127
Wang, A., & Zhong, H. (2018) · Hematology · doi:10.1080/10245332.2018.1486064 · Cited by 123
Li, G.-Q., Guo, W.-Z., Zhang, Y., Seng, J.-J., Zhang, H., Ma, X.-X., Zhang, G., Li, J., Yan, B., Tang, H., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6275 · Cited by 121
Deneberg, S., Grövdal, M., Karimi, M., Jansson, M., Nahi, H., Corbacioglu, A., Gaidzik, V. I., Döhner, K., Paul, C., Ekström, T. J., et al. (2010) · Leukemia · doi:10.1038/leu.2010.41 · Cited by 120
Distinct C/EBP functions are required for eosinophil lineage commitment and maturation
Nerlov, C., McNagny, K. M., Döderlein, G., Kowenz-Leutz, E., & Graf, T. (1998) · Genes & Development · doi:10.1101/gad.12.15.2413 · Cited by 119
New insights into the role of PML in tumour suppression
Salomoni, P., Ferguson, B. J., Wyllie, A. H., & Rich, T. (2008) · Cell Research · doi:10.1038/cr.2008.58 · Cited by 119
Bruserud, Ø., Gjertsen, B. T., Foss, B., & Huang, T. (2001) · Stem Cells · doi:10.1634/stemcells.19-1-1 · Cited by 117
Chotirat, S., Thongnoppakhun, W., Promsuwicha, O., Boonthimat, C., & Auewarakul, C. U. (2012) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-5-5 · Cited by 116
Nelson, E. A., Walker, S. R., Xiang, M. H., Weisberg, E., Bar‐Natan, M., Barrett, R., Liu, S., Kharbanda, S. M., Christie, A. L., Nicolais, M., et al. (2012) · Genes & Cancer · doi:10.1177/1947601912466555 · Cited by 116
Campbell, F. R. (1972) · American Journal of Anatomy · doi:10.1002/aja.1001350406 · Cited by 113
Bone marrow microenvironment–derived signals induce Mcl-1 dependence in multiple myeloma
Gupta, V. A., Matulis, S. M., Conage-Pough, J. E., Nooka, A. K., Kaufman, J. L., Lonial, S., & Boise, L. H. (2017) · Blood · doi:10.1182/blood-2016-10-745059 · Cited by 113
Kurtz, S. E., Eide, C. A., Kaempf, A. J., Khanna, V., Savage, S. L., Rofelty, A., English, I. A., Ho, H., Pandya, R., Bolosky, W. J., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1703094114 · Cited by 113
Sun, B., Shah, B., Fiskus, W. C., Qi, J., Rajapakshe, K., Coarfa, C., Li, L., Devaraj, S. G. T., Sharma, S., Zhang, L., et al. (2015) · Blood · doi:10.1182/blood-2015-04-639542 · Cited by 111
Santamaría, C., Muntión, S., Rosón, B., Blanco, B., López‐Villar, O., Carrancio, S., Sanchez-Guijo, F. M., Díez‐Campelo, M., Álvarez-Fernández, S., Sarasquete, M. E., et al. (2012) · Haematologica · doi:10.3324/haematol.2011.054437 · Cited by 111
Kojima, K., McQueen, T. J., Chen, Y., Jacamo, R. O., Konopleva, M. Y., Shinojima, N., Shpall, E. J., Huang, X., & Andreeff, M. (2011) · Blood · doi:10.1182/blood-2011-02-334136 · Cited by 109
RARAfusion genes in acute promyelocytic leukemia: a review
Braekeleer, E. D., Douet‐Guilbert, N., & Braekeleer, M. D. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.903794 · Cited by 107
Paschka, P., Schlenk, R. F., Weber, D., Benner, A., Bullinger, L., Heuser, M., Gaidzik, V. I., Thol, F. R., Agrawal, M., Teleanu, V., et al. (2018) · Leukemia · doi:10.1038/s41375-018-0129-6 · Cited by 107
Characterization of acute myeloid leukemia based on levels of global hydroxymethylation
Kroeze, L. I., Aslanyan, M. G., van Rooij, A., Koorenhof‐Scheele, T. N., Massop, M., Carell, T., Boezeman, J. B. M., Marie, J., Halkes, C. J. M., de Witte, T., et al. (2014) · Blood · doi:10.1182/blood-2013-08-518514 · Cited by 101
A Proteomics and Transcriptomics Approach to Identify Leukemic Stem Cell (LSC) Markers
Bonardi, F., Fusetti, F., Deelen, P., van Gosliga, D., Vellenga, E., & Schuringa, J. J. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.021931 · Cited by 97
Parmar, A., Marz, S., Rushton, S. N., Holzwarth, C., Lind, K., Käyser, S., Döhner, K., Peschel, C., Oostendorp, R. A. J., & Götze, K. S. S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4136 · Cited by 96
Epigenetics in Acute Myeloid Leukemia
Plass, C., Oakes, C. C., Blum, W. G., & Marcucci, G. (2008) · Seminars in Oncology · doi:10.1053/j.seminoncol.2008.04.008 · Cited by 96
Handbook of hormones : comparative endocrinology for basic and clinical research
竹井, 祥., 安東, 宏., & 筒井, 和. (2016) · Elsevier eBooks · Cited by 93
Sakurai, M., Kunimoto, H., Watanabe, N., Fukuchi, Y., Yuasa, S., Yamazaki, S., Nishimura, T., Sadahira, K., Fukuda, K., Okano, H., et al. (2014) · Leukemia · doi:10.1038/leu.2014.136 · Cited by 91
Álvarez, S., Suela, J., Valencia, A., Fernández, A. F., Wunderlich, M., Agirre, X., Prósper, F., Martín-Subero, J. I., Maiqués-Díaz, A., Acquadro, F., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012197 · Cited by 91
Au, C. H., Wa, A., Ho, D. N., Chan, T. L., & Ma, E. S. K. (2016) · Diagnostic Pathology · doi:10.1186/s13000-016-0456-8 · Cited by 87
Emadi, A., Faramand, R. G., Carter‐Cooper, B., Tolu, S. S., Ford, L. A., Lapidus, R. G., Wetzler, M., Wang, E. S., Etemadi, A., & Griffiths, E. A. (2015) · American Journal of Hematology · doi:10.1002/ajh.23965 · Cited by 82
Patel, A. J., Liao, C.-P., Chen, Z., Liu, C., Wang, Y., & Le, L. Q. (2014) · Cell Reports · doi:10.1016/j.celrep.2013.12.001 · Cited by 82
HOX gene expression predicts response to BCL-2 inhibition in acute myeloid leukemia
Kontro, M., Kumar, A., Majumder, M. M., Eldfors, S., Parsons, A., Pemovska, T., Saarela, J., Yadav, B., Malani, D., Fløisand, Y., et al. (2016) · Leukemia · doi:10.1038/leu.2016.222 · Cited by 82
Update on rational targeted therapy in AML
Shafer, D. A., & Grant, S. (2016) · Blood Reviews · doi:10.1016/j.blre.2016.02.001 · Cited by 79
Saied, M. H., Marzec, J., Khalid, S., Smith, P., Down, T. A., Rakyan, V. K., Molloy, G., Raghavan, M., Debernardi, S., & Young, B. D. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033213 · Cited by 75
Marková, J., Michková, P., Burčková, K., Březinová, J., Michalova, K., Dohnalova, A., Maaloufová, J., Soukup, P., Vı́tek, A., Cetkovský, P., et al. (2011) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2011.01716.x · Cited by 74
Core‐binding factor acute myeloid leukemia: Heterogeneity, monitoring, and therapy
Solh, M., Yohe, S. L., Weisdorf, D. J., & Üstün, C. (2014) · American Journal of Hematology · doi:10.1002/ajh.23821 · Cited by 74
Johnson-Farley, N. N., Veliz, J., Bhagavathi, S., & Bertino, J. R. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.981172 · Cited by 74
Weisberg, E., Liu, Q., Nelson, E. A., Kung, A. L., Christie, A. L., Bronson, R. T., Sattler, M., Sanda, T., Zhao, Z., Hur, W., et al. (2012) · Leukemia · doi:10.1038/leu.2012.96 · Cited by 73
Epigenetic aberrations in acute myeloid leukemia: Early key events during leukemogenesis
Eriksson, A., Lennartsson, A., & Lehmann, S. (2015) · Experimental Hematology · doi:10.1016/j.exphem.2015.05.009 · Cited by 72
Loke, J. C. T., Khan, J. N., Wilson, J. S., Craddock, C., & Wheatley, K. (2014) · Annals of Hematology · doi:10.1007/s00277-014-2218-6 · Cited by 71
Kunimoto, H., Fukuchi, Y., Sakurai, M., Sadahira, K., Ikeda, Y., Okamoto, S., & Nakajima, H. (2012) · Scientific Reports · doi:10.1038/srep00273 · Cited by 71
Peirs, S., Frismantas, V., Matthijssens, F., Loocke, W. V., Pieters, T., Vandamme, N., Lintermans, B., Dobay, M. P., Berx, G., Poppe, B. G., et al. (2017) · Leukemia · doi:10.1038/leu.2017.10 · Cited by 71
Hammerlindl, H., & Schaider, H. (2017) · Journal of Cell Communication and Signaling · doi:10.1007/s12079-017-0435-1 · Cited by 71
Spijkers-Hagelstein, J. A. P., Schneider, P., Hulleman, E., de Boer, J., Williams, O., Pieters, R., & Stam, R. W. (2012) · Leukemia · doi:10.1038/leu.2011.388 · Cited by 69
Epigenetic Therapy in Acute Myeloid Leukemia: Current and Future Directions
Kim, T. K., Gore, S. D., & Zeidan, A. M. (2015) · Seminars in Hematology · doi:10.1053/j.seminhematol.2015.04.003 · Cited by 69
AMLSG, A. F. T. G.-A., Schlenk, R. F., Frech, P., Weber, D., Brossart, P., Horst, H., Kraemer, D. M., Held, G., Ringhoffer, M., Burchardt, A. C., et al. (2017) · Leukemia · doi:10.1038/leu.2017.22 · Cited by 69
Mixed lineage leukemia: roles in human malignancies and potential therapy
Marschalek, R. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07608.x · Cited by 68
Reproducibility-Optimized Test Statistic for Ranking Genes in Microarray Studies
Elo, L. L., Filén, S., Lahesmaa, R., & Aittokallio, T. A. (2008) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2007.1078 · Cited by 68
MicroRNA-125b transforms myeloid cell lines by repressing multiple mRNA
Bousquet, M., Nguyen, D. T. T., Chen, C., Shields, L., & Lodish, H. F. (2012) · Haematologica · doi:10.3324/haematol.2011.061515 · Cited by 66
Guryanova, O. A., Lieu, Y. K., Garrett-Bakelman, F. E., Spitzer, B., Glass, J. L., Shank, K., Martinez, A. B. V., Rivera, S. A., Durham, B. H., Rapaport, F., et al. (2016) · Leukemia · doi:10.1038/leu.2015.358 · Cited by 66
Roboz, G. J., Kantarjian, H. M., Yee, K. W. L., Kropf, P. L., O'Connell, C. L., Griffiths, E. A., Stock, W., Daver, N. G., Jabbour, E. J., Ritchie, E. K., et al. (2017) · Cancer · doi:10.1002/cncr.31138 · Cited by 66
RAS mutation analysis in a large cohort of Chinese patients with acute myeloid leukemia
Yang, X., Qian, J., Sun, A., Lin, J., Xiao, G.-F., Yin, J., Chen, S., & Wu, D. (2013) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2012.12.022 · Cited by 65
Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients
Nicolas‐Virelizier, E., Ramus, C., Berthier, S., Arlotto, M., Bouamrani, A., Lefebvre, C., Morel, F., Garin, J., Ifrah, N., Berger, F. R., et al. (2010) · Leukemia · doi:10.1038/leu.2010.251 · Cited by 65
The role of mutations in epigenetic regulators in myeloid malignancies
Woods, B. A., & Levine, R. L. (2014) · Immunological Reviews · doi:10.1111/imr.12246 · Cited by 64
Zhang, W., Borthakur, G. M., Chen, G., Chen, Y., Mu, H., Ruvolo, V. R., Nomoto, K., Zhao, N., Konopleva, M. Y., & Andreeff, M. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1580 · Cited by 61
Faderl, S. H., Harris, D., Van, Q., Kantarjian, H. M., Talpaz, M., & Estrov, Z. E. (2003) · Blood · doi:10.1182/blood-2002-06-1890 · Cited by 59
DNA Methylation Screening and Analysis
Sant, K. E., Nahar, M. S., & Dolinoy, D. C. (2012) · Methods in molecular biology · doi:10.1007/978-1-61779-867-2_24 · Cited by 56
Gene mutations and molecularly targeted therapies in acute myeloid leukemia.
Hatzimichael, E. C., Georgiou, G. K., Benetatos, L., & Briasoulis, E. C. (2013) · Europe PMC (PubMed Central) · Cited by 53
Balkhi, M. Y., Trivedi, A. K., Geletu, M., Christopeit, M., Bohlander, S. K., Behre, H. M., & Behre, G. (2006) · Oncogene · doi:10.1038/sj.onc.1209689 · Cited by 53
The impact of RNA sequence library construction protocols on transcriptomic profiling of leukemia
Kumar, A., Kankainen, M., Parsons, A., Kallioniemi, O., Mattila, P., & Heckman, C. A. (2017) · BMC Genomics · doi:10.1186/s12864-017-4039-1 · Cited by 53
The Diagnostic Value of DNA Methylation in Leukemia: A Systematic Review and Meta-Analysis
Jiang, D., Hong, Q., Shen, Y., Xu, Y., Zhu, H., Li, Y., Xu, C., Ouyang, G., & Duan, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096822 · Cited by 52
Chang, Y., You, X., Kong, G., Ranheim, E. A., Wang, J., Du, J., Liu, Y., Zhou, Y., Ryu, M.-J., & Zhang, J. (2015) · Leukemia · doi:10.1038/leu.2015.85 · Cited by 52
Roboz, G. J., Ritchie, E. K., Dault, Y., Lam, L., Marshall, D. C., Cruz, N. M., Hsu, H.-T., Hassane, D. C., Christos, P. J., Ippoliti, C. M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.183418 · Cited by 52
Cleven, A. H. G., Nardi, V., Ok, C. Y., Goswami, M., Cin, P. D., Zheng, Z., Iafrate, A. J., Hamid, M. A. A., Wang, S. A., & Hasserjian, R. P. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.153 · Cited by 51
Liu, W.-J., Tan, X., Luo, X., Guo, B.-P., Wei, Z.-J., Ke, Q., He, S., & Cen, H. (2014) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2014.893308 · Cited by 51
Cho, J., Kim, J. J., Park, S. G., Lee, D. H., Lee, S. C., Kim, H., Park, B. C., & Cho, S. (2004) · PROTEOMICS · doi:10.1002/pmic.200400968 · Cited by 42
Genomics of Acute Myeloid Leukemia: The Next Generation
Riva, L., Luzi, L., & Pelicci, P. G. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00040 · Cited by 42
Emerging diagnostic and therapeutic approaches in core binding factor acute myeloid leukaemia
Üstün, C., & Marcucci, G. (2015) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000124 · Cited by 38
Impact of S100A8/A9 Expression on Prostate Cancer Progression In Vitro and In Vivo
Grebhardt, S., Müller‐Decker, K., Bestvater, F., Hershfinkel, M., & Mayer, D. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24489 · Cited by 37
Midostaurin in FLT3-Mutated Acute Myeloid Leukemia
Sahoo, R. K., & Kumar, L. (2017) · New England Journal of Medicine · doi:10.1056/nejmc1711340 · Cited by 37
Prognosis and monitoring of core-binding factor acute myeloid leukemia: current and emerging factors
Duployez, N., Willekens, C., Marceau‐Renaut, A., Boudry‐Labis, E., & Preudhomme, C. (2014) · Expert Review of Hematology · doi:10.1586/17474086.2014.976551 · Cited by 32
Blom, K., Nygren, P., Larsson, R. L., & Andersson, C. R. (2017) · SLAS TECHNOLOGY · doi:10.1177/2472630316686297 · Cited by 32
Cattaneo, M., Pelosi, E., Castelli, G., Cerio, A. M., D′angiò, A., Porretti, L., Rebulla, P., Pavesi, L., Russo, G., Giordano, A., et al. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.24876 · Cited by 31
miR-21 is overexpressed in NPM1-mutant acute myeloid leukemias
Riccioni, R., Lulli, V., Castelli, G., Biffoni, M., Tiberio, R., Pelosi, E., Lo‐Coco, F., & Testa, U. (2014) · Leukemia Research · doi:10.1016/j.leukres.2014.11.001 · Cited by 31
Tickenbrock, L., Klein, H., Trento, C., Hascher, A., Göllner, S., Bäumer, N., Kuss, R., Agrawal, S., Bug, G., Serve, H. L., et al. (2010) · Leukemia Research · doi:10.1016/j.leukres.2010.11.006 · Cited by 31
Quintarelli, C., Angelis, B. D., Errichiello, S., Caruso, S., Esposito, N., Colavita, I., Raia, M., Pagliuca, S., Pugliese, N., Risitano, A. M., et al. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.11.006 · Cited by 29
Regulation of the Flt3 Gene in Haematopoietic Stem and Early Progenitor Cells
Volpe, G., Clarke, M. L., García, P., Walton, D. S., Vegiopoulos, A., Pozzo, W. D., O’Neill, L. P., Frampton, J., & Dumon, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0138257 · Cited by 28
Zhuang, W., Cen, J., Zhao, Y., & Chen, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2459 · Cited by 27
Xu, L., Guo, Y., Zhang, X., Chen, J., & Hu, S. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000443046 · Cited by 27
Assessment of Minimal Residual Disease in Standard-Risk AML.
Hills, R. K., Ivey, A., & Grimwade, D. J. (2016) · PubMed · doi:10.1056/nejmc1603847 · Cited by 27
Epigenetic Biomarkers: Potential Applications in Gastrointestinal Cancers
Li, J., Jin, H., & Wang, X. (2014) · ISRN Gastroenterology · doi:10.1155/2014/464015 · Cited by 26
Proteomic Classification of Acute Leukemias by Alignment-Based Quantitation of LC–MS/MS Data Sets
Foss, E. J., Radulovic, D., Stirewalt, D. L., Radich, J. P., Torra, O. S., Pogosova‐Agadjanyan, E. L., Hengel, S. M., Loeb, K. R., Deeg, H. J., Meshinchi, S., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300567r · Cited by 25
Hou, H. A., Tang, J., Lin, L., et al. (2009) · Blood · doi:10.1182/blood.v114.22.1564.1564 · Cited by 24
Mouse models for core binding factor leukemia
Chin, D. W. L., Watanabe‐Okochi, N., Wang, C. Q., Tergaonkar, V., & Osato, M. (2015) · Leukemia · doi:10.1038/leu.2015.181 · Cited by 23
MicroRNA–mRNA Pairs Associated with Outcome in AML: From In Vitro Cell-Based Studies to AML Patients
Bhise, N., Chauhan, L., Shin, M., Cao, X., Pounds, S. B., Lamba, V., & Lamba, J. K. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00324 · Cited by 22
Ten‐Eleven‐Translocation 2 ( TET 2) is downregulated in myelodysplastic syndromes
Scopim‐Ribeiro, R., Machado‐Neto, J. A., Campos, P. D. M., Silva, C. A. M., Favaro, P. M. B., Lorand-Metze, I. G. H., Costa, F. F., Saad, S. T. O., & Traina, F. (2014) · European Journal Of Haematology · doi:10.1111/ejh.12445 · Cited by 21
Bujko, M., Musialik‐Świetlińska, E., Olbromski, R., Przestrzelska, M., Libura, M. A., Pastwińska, A., Juszczyński, P., Zwierzchowski, L., Baranowski, P., & SIEDLECKI, J. A. (2014) · International Journal of Hematology · doi:10.1007/s12185-014-1592-0 · Cited by 20
Ghannam, D. M. E., Taalab, M. M., Ghazy, H. F. A.-E. H., & Eneen, A. (2014) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2014.01.004 · Cited by 20
Kurtz, S. E., Eide, C. A., Kaempf, A., Mori, M., Tognon, C. E., Borate, U., Druker, B. J., & Tyner, J. W. (2018) · Leukemia · doi:10.1038/s41375-018-0225-7 · Cited by 20
Claus, R., Plass, C., Armstrong, S. A., & Bullinger, L. (2010) · Future Oncology · doi:10.2217/fon.10.110 · Cited by 19
RUNX1/ETO blocks selectin-mediated adhesion via epigenetic silencing of PSGL-1
Ponnusamy, K., Kohrs, N., Ptasinska, A., Assi, S. A., Herold, T., Hiddemann, W., Lausen, J., Bonifer, C., Henschler, R., & Wichmann, C. W. (2015) · Oncogenesis · doi:10.1038/oncsis.2015.6 · Cited by 17
Long, Z., Hu, Y., Li, X.-D., He, Y. J., Xiao, R.-Z., Fang, Z.-G., Dong-ning, W., Liu, J., Yan, J., Huang, R., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104610 · Cited by 16
Elo, L. L., Karjalainen, R., Öhman, T., Hintsanen, P., Nyman, T. A., Heckman, C. A., & Aittokallio, T. A. (2014) · PROTEOMICS · doi:10.1002/pmic.201300460 · Cited by 15
Progress in Mining the Human Proteome for Disease Applications
Hanash, S. (2011) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2010.0111 · Cited by 14
Chemotherapy options for previously untreated acute myeloid leukemia
Lynch, R. C., & Medeiros, B. C. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1076795 · Cited by 13
Al‐Ali, H. K., Cross, M. A., Bach, E., Krahl, R., Jaekel, N., Niederwieser, D. W., Junghanß, C., Maschmeyer, G., & Tran (2013) · OncoTargets and Therapy · doi:10.2147/ott.s45459 · Cited by 13
MicroRNAs mark in the MLL-rearranged leukemia
Benetatos, L., & Vartholomatos, G. (2013) · Annals of Hematology · doi:10.1007/s00277-013-1803-4 · Cited by 11
Stem Cell Modeling of Core Binding Factor Acute Myeloid Leukemia
Mosna, F., & Gottardi, M. (2016) · Stem Cells International · doi:10.1155/2016/7625827 · Cited by 11
Richarson, A. D., Scott, D. A., Zagnitko, O. P., Aza‐Blanc, P., Chang, C., Russler‐Germain, D. A., & Reproducibility Project: Cancer Biology (2016) · eLife · doi:10.7554/elife.10860 · Cited by 11
Metadata
- Authors
- Prada-Arismendy, J., Arroyave, J. C., & Röthlisberger, S.
- Venue
- Blood Reviews
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 31
- Issue
- 1
- Pages
- 63-76
- ISSN
- 0268-960X (ISSN-L)
- OpenAlex
- W2509517672
- Cited by
- 304
- References
- 346
- FWCI
- 10.01
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.